NOVEN TO PRESENT AT R.W. BAIRD GROWTH STOCK CONFERENCE |
BackMiami, FL, May 9,
2008 -- Noven Pharmaceuticals, Inc. (NASDAQ: NOVN) today announced
that Jeffrey F. Eisenberg, Noven's Executive Vice President,
is scheduled to present an update on Noven’s business and prospects
at the Robert W. Baird 2008 Growth Stock Conference in Chicago, IL
on Tuesday, May 13 at 1:55 p.m. CT (2:55 p.m. ET). The presentation
will be webcast live at www.noven.com, and a rebroadcast will be available
thereafter at the same site.
About Noven
Noven Pharmaceuticals, Inc.
is a specialty pharmaceutical company engaged in the research, development,
manufacture, marketing and sale of prescription pharmaceutical products.
Noven's business and operations are focused in three principal
areas – transdermal drug delivery, the Novogyne joint venture,
and its Noven Therapeutics specialty pharmaceutical unit.
Contact:
|
Copyright © 2008 Noven Pharmaceuticals, Inc. All rights reserved.